Skip to content
cccskills
FreePublished on GitHub

es-cushing-serum-sodium-monitoring-post-tss

This skill recommends measuring serum sodium several times during the first 5–14 days after transsphenoidal surgery to detect and manage electrolyte disturbances such as postoperative hyponatremia and diabetes insipidus. Use when managing a post-TSS Cushing’s syndrome patient in the early recovery phase; triggers include postoperative day 5–10 hyponatremia, polyuria, fluid intake‑output imbalance, or suspected diabetes insipidus.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14 stars(GitHub 14 + cccskills 0)

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.2 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Serum Sodium Monitoring Several Times During First 5-14 Days Post-TSS

STEP 1 — Gather Information

Record postoperative day, serum sodium, fluid intake and output (urine volume, IV fluids), weight change, vital signs, and neuro symptoms (confusion, headache, seizures).

STEP 2 — Rule In / Rule Out

Determine if serum sodium is low (<135 mmol/L) suggesting SIADH, high (>145 mmol/L) suggesting diabetes insipidus, or normal with high urine output (>200 mL/hr) suggestive of DI.

STEP 3 — Classify or Stratify

Classify the disturbance as SIADH, diabetes insipidus, or electrolyte stable based on sodium trend, urine output, and clinical context.

STEP 4 — Decide

Initiate fluid restriction (800–1000 mL/day) and frequent sodium checks for SIADH; start desmopressin (1–2 mcg IV/PO q6–8h) and monitor urine output and sodium for DI; involve endocrinology for both.

Clinical Guardrails / Mimics / Pitfalls

Avoid rapid sodium correction (>6–8 mmol/L in 24 h) to prevent osmotic demyelination; do not give free water in hyponatremia; do not administer desmopressin without confirmed DI; watch for over‑correction when switching from SIADH to DI; ensure emergency staff know to contact endocrinology for hyponatremia post‑TSS.

Concrete Clinical Example

A 48‑year‑man postoperative day 9 after TSS for Cushing’s disease has serum Na 126 mmol/L, urine output 25 mL/hr, 1.5 kg weight gain, and mild lethargy. Fluid restricted to 800 mL/day, sodium checked every 4 h, endocrinology consulted; sodium rises to 132 mmol/L by day 11.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2015-1818

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill